ReviewCell death discovery2022

Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Ya Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.